Atopic Dermatitis (Eczema) - CPL | US
Offer Details: | |
|---|---|
| Offer Name: | Atopic Dermatitis (Eczema) - CPL | US |
| Payout: | $60.00 / CPA |
| Preview: | Preview Landing Page |
| Categories: | Ecommerce |
| Network: | DYNU IN MEDIA |
| Last Updated: | Mar 18, 2026 |
| Countries: | US |
Ages: 18 - 75
Gender: All
Reach: 16% of the US population
ONLY COMPENSATION THAT CAN BE LISTED: Participants who qualify for the study will receive trial-related procedures and study medication at no cost.
Study Description: The purpose of this clinical study is to see whether an investigational injectable medication can help to treat symptoms of moderate to severe Atopic Dermatitis (eczema). You may qualify to participate if you were diagnosed with Atopic Dermatitis at least 1 year ago and are currently experiencing symptoms. You may be asked to attend an initial screening visit to determine if you’re eligible to enroll in the study. If enrolled, you will be randomly selected to receive 2 injections of either the study medication or a placebo. Total participation will last approximately 7 months with 16 doctor’s visits throughout the study. Participants who qualify for the study will receive trial-related procedures and study medication at no cost. The site staff can provide you with additional details.
- Must be diagnosed with eczema for one year or longer
- Must be currently experiencing a current flare of eczema
- Eczema must cover 10% or more of your body
- Have to be using an injectable medication for your eczema
Proof required for approval
Gender: All
Reach: 16% of the US population
ONLY COMPENSATION THAT CAN BE LISTED: Participants who qualify for the study will receive trial-related procedures and study medication at no cost.
Study Description: The purpose of this clinical study is to see whether an investigational injectable medication can help to treat symptoms of moderate to severe Atopic Dermatitis (eczema). You may qualify to participate if you were diagnosed with Atopic Dermatitis at least 1 year ago and are currently experiencing symptoms. You may be asked to attend an initial screening visit to determine if you’re eligible to enroll in the study. If enrolled, you will be randomly selected to receive 2 injections of either the study medication or a placebo. Total participation will last approximately 7 months with 16 doctor’s visits throughout the study. Participants who qualify for the study will receive trial-related procedures and study medication at no cost. The site staff can provide you with additional details.
- Must be diagnosed with eczema for one year or longer
- Must be currently experiencing a current flare of eczema
- Eczema must cover 10% or more of your body
- Have to be using an injectable medication for your eczema
Proof required for approval
DYNU IN MEDIA
DYNU IN MEDIA is a super match CPA/CPL network for earning money online that provides you with all techniques allowing you to monetize your traffic in all channels. We guarantee outstanding support to our publishers. Our devoted team with experience in the affiliate marketing industry will give you full-assist, direct offers in a wide-ranging variety of verticals and top GEOs, and a flexible payment schedule of NET15 & NET30. Hitting more than 20,000 leads generated daily for over 200 influential clients, along with an increasing number of HQ publishers to 300 and more, DYNU IN MEDIA is taking high pride in our professionalism and high integrity.
